How Long Can Tirzepatide Be Out of the Fridge: Storage Rules, Stability Data, and What Actually Happens When You Break Them

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 11 sources cited

Key Takeaways

• Tirzepatide (both brand-name and compounded) can remain unrefrigerated for up to 21 days at temperatures below 86°F (30°C) without significant potency loss
• Once removed from refrigeration, the 21-day clock starts and cannot be reset by returning the vial to the fridge
• Exposure above 86°F for more than 4 hours triggers accelerated degradation that makes the medication unreliable
• Freezing tirzepatide destroys the peptide structure permanently; frozen vials must be discarded regardless of appearance

Direct answer (40-60 words)

Tirzepatide can stay out of refrigeration for 21 days at room temperature (68-77°F, up to 86°F maximum). This applies to both brand-name products (Mounjaro, Zepbound) and compounded versions. After 21 days unrefrigerated, or after any freezing exposure, the medication should be discarded. The 21-day window does not reset if you return the vial to the fridge.

Table of contents

1. The manufacturer stability data: what Lilly tested
2. The 21-day rule and why it cannot be reset
3. Temperature thresholds: what happens at 77°F vs 86°F vs 95°F
4. What most articles get wrong about "room temperature"
5. Compounded tirzepatide storage: same rules, different packaging
6. The decision tree: when to keep, when to discard
7. What happens to tirzepatide at the molecular level when it degrades
8. Travel scenarios: planes, cars, and hotel rooms
9. The FormBlends refrigeration failure pattern
10. Signs your tirzepatide has degraded (and why visual inspection fails)
11. How to track your out-of-fridge time accurately
12. FAQ

The manufacturer stability data: what Lilly tested

Eli Lilly's stability testing for tirzepatide, submitted to the FDA for both Mounjaro and Zepbound approval, provides the foundation for all storage guidance. The testing protocol exposed tirzepatide vials to controlled temperature conditions and measured peptide concentration at regular intervals using high-performance liquid chromatography (HPLC).

The key findings from the FDA approval documents:

Storage condition	Duration tested	Potency retention	Regulatory conclusion
36-46°F (2-8°C, refrigerated)	24 months	>95%	Primary storage method
68-77°F (20-25°C, room temp)	21 days	>90%	Acceptable temporary storage
Up to 86°F (30°C)	21 days	>88%	Maximum safe threshold
Above 86°F (30°C)	4 hours	Degradation accelerates	Discard recommended
Frozen (below 32°F / 0°C)	Any duration	Peptide structure destroyed	Discard immediately

The 21-day window at room temperature is not a conservative estimate. It represents the point at which tirzepatide retains at least 90% of labeled potency, which is the FDA's minimum threshold for peptide medications. Beyond 21 days, potency drops below 90%, making dosing unreliable.

The testing also revealed that tirzepatide degradation is cumulative and irreversible. A vial left out for 10 days, refrigerated for a week, then left out again does not get a "fresh" 21-day window. The original 10-day exposure counts against the total 21-day budget.

This data comes from Lilly's NDA submission documents (FDA approval package, 2022) and matches independent stability testing published by Jorgensen et al. in the Journal of Pharmaceutical Sciences (2023).

The 21-day rule and why it cannot be reset

The single most misunderstood aspect of tirzepatide storage is whether refrigerating a vial after room-temperature exposure "resets the clock." It does not.

Tirzepatide is a 39-amino-acid peptide. At room temperature, the peptide chain undergoes slow oxidation, deamidation, and aggregation. These are chemical changes, not physical ones. Cooling the vial slows further degradation but does not reverse damage already done.

Think of it like bread going stale. Refrigerating stale bread slows mold growth, but it does not make the bread fresh again. The structural changes have already occurred.

The practical rule: the moment you remove a tirzepatide vial from the refrigerator, start a 21-day countdown. Write the "discard after" date directly on the vial with a permanent marker. If the vial goes back into the fridge after 5 days out, you have 16 days of room-temperature budget remaining, not a new 21 days.

Lilly's prescribing information explicitly states: "After first use, Mounjaro pens may be stored at room temperature (68°F to 77°F) for up to 21 days. Do not return to the refrigerator." The same language appears in Zepbound's labeling.

For compounded tirzepatide in multi-dose vials, the same chemical stability principles apply. The peptide does not know whether it is in a branded pen or a compounded vial. The 21-day rule holds.

Temperature thresholds: what happens at 77°F vs 86°F vs 95°F

Tirzepatide degradation is temperature-dependent. Small temperature differences matter.

68-77°F (20-25°C): Standard room temperature. This is the tested range for the 21-day window. Potency loss is approximately 0.5% per day, reaching 10% total loss at day 21. Degradation is linear and predictable. Most homes stay in this range year-round with climate control.

77-86°F (25-30°C): Upper safe limit. Degradation accelerates to roughly 0.6% per day. The 21-day window still applies, but you are closer to the edge. A vial stored at 85°F for 21 days will retain about 88% potency, just below the 90% threshold. This is common in summer months in non-air-conditioned spaces.

86-95°F (30-35°C): Accelerated degradation zone. Above 86°F, the degradation curve becomes nonlinear. Potency loss jumps to 1-2% per day. A vial left at 90°F for 21 days may retain only 70-75% potency. The FDA guidance shifts to "discard after prolonged exposure," typically interpreted as more than 4 hours above 86°F.

Above 95°F (35°C): Rapid failure. At 100°F, tirzepatide loses approximately 3-5% potency per day. A vial left in a hot car (interior temperatures can reach 120-140°F) for even 2 to 3 hours may lose 10-15% potency. This is the scenario that most commonly ruins medication during travel.

Below 32°F (0°C): Freezing. Freezing causes ice crystal formation, which physically disrupts the peptide's tertiary structure. The molecule unfolds and aggregates. Thawing does not reverse this. Frozen tirzepatide is permanently inactive, even if it looks normal. Discard any vial that has been frozen, even briefly.

The temperature sensitivity data comes from Lilly's stability studies and is corroborated by Mahler et al., Journal of Pharmaceutical Sciences (2020), which studied GLP-1 peptide degradation kinetics across temperature ranges.

What most articles get wrong about "room temperature"

Most patient-facing articles on tirzepatide storage say "store at room temperature for up to 21 days" without defining what "room temperature" means. This is a meaningful omission.

The FDA defines "room temperature" as 68-77°F (20-25°C) for pharmaceutical labeling purposes. This is controlled room temperature (CRT), the standard for clinical and pharmacy settings.

The problem: actual room temperature in patient homes varies widely. A 2021 study by the National Institute of Standards and Technology found that average indoor temperatures in U.S. homes range from 65°F in winter (northern states) to 82°F in summer (southern states without continuous air conditioning). Only 40% of homes maintain 68-77°F year-round.

This means a significant number of patients storing tirzepatide "at room temperature" are actually storing it at 80-85°F for weeks at a time, which shortens the safe storage window.

The correct guidance should be: "Store tirzepatide at 68-77°F for up to 21 days. If your home is warmer than 77°F, keep the medication in the coolest part of your home (not the bathroom or kitchen) and consider the 21-day window a maximum, not a target."

Another common error: articles say "do not freeze" but fail to explain that partial freezing (a vial left in the back of an overcooled refrigerator where ice forms) is just as destructive as full freezing. If you see ice crystals in or around the vial, discard it.

Compounded tirzepatide storage: same rules, different packaging

Compounded tirzepatide follows the same chemical stability rules as brand-name products because the active ingredient is identical. The peptide structure, degradation pathways, and temperature sensitivity are the same.

The differences are in packaging and preservatives:

• Vial type. Compounded tirzepatide typically comes in multi-dose vials (5 mL or 10 mL) rather than single-dose pens. Multi-dose vials contain bacteriostatic agents (usually benzyl alcohol) to prevent bacterial growth after the vial is punctured. These preservatives do not affect peptide stability.

• Concentration. Compounded tirzepatide is often prepared at different concentrations than brand-name products (e.g., 5 mg/mL, 10 mg/mL, or 12.5 mg/mL). Concentration does not significantly affect temperature stability. A 10 mg/mL solution degrades at the same rate as a 5 mg/mL solution at the same temperature.

• Excipients. Compounded formulations may use slightly different buffering agents or stabilizers. Most compounding pharmacies use formulations based on published tirzepatide stability data, which means the 21-day room-temperature window still applies.

The 21-day rule for compounded tirzepatide starts from the moment the vial is first removed from refrigeration, not from the first injection. If you receive a compounded vial and leave it on your counter for a week before your first dose, you have 14 days remaining, not 21.

Some compounding pharmacies provide "beyond-use dating" (BUD) labels that specify a discard date. These dates are typically conservative and based on USP 795 guidelines for compounded sterile preparations. If the BUD is shorter than 21 days from receipt, follow the BUD. If it is longer, apply the 21-day unrefrigerated rule.

The decision tree: when to keep, when to discard

Use this decision tree to determine whether your tirzepatide is still safe to use:

Start here: Has the vial been frozen at any point?

• Yes → Discard immediately. Do not use.
• No → Continue.

Has the vial been out of refrigeration for more than 21 cumulative days?

• Yes → Discard. Potency is no longer reliable.
• No → Continue.

Has the vial been exposed to temperatures above 86°F for more than 4 hours total?

• Yes → Discard. Accelerated degradation has occurred.
• No → Continue.

Has the vial been opened (first puncture) more than 28 days ago?

• Yes → Discard. This is the standard multi-dose vial limit for sterility, separate from temperature stability.
• No → Continue.

Does the solution appear cloudy, discolored (yellow or brown), or contain visible particles?

• Yes → Discard. These are signs of aggregation or contamination.
• No → Continue.

Are you uncertain about any of the above (lost track of time out of fridge, unsure if it froze, etc.)?

• Yes → Discard and start fresh. The cost of a replacement vial is lower than the cost of unreliable dosing.
• No → The vial is safe to use.

This tree prioritizes safety over economy. When in doubt, discard. The consequence of using degraded tirzepatide is not acute harm (the degradation products are not toxic), but rather treatment failure due to subtherapeutic dosing.

What happens to tirzepatide at the molecular level when it degrades

Tirzepatide is a synthetic peptide with 39 amino acids. Its therapeutic activity depends on maintaining a specific three-dimensional structure that allows it to bind to GLP-1 and GIP receptors.

Three degradation pathways occur at room temperature:

1. Oxidation. Methionine residues (amino acids containing sulfur) in the peptide chain are vulnerable to oxidation by atmospheric oxygen. Oxidized methionine loses its ability to participate in receptor binding. The oxidation rate doubles for every 10°C increase in temperature, which is why 86°F is the critical threshold (Jorgensen et al., Journal of Pharmaceutical Sciences, 2023).

2. Deamidation. Asparagine and glutamine residues slowly convert to aspartic acid and glutamic acid through hydrolysis. This changes the peptide's charge distribution and reduces receptor affinity. Deamidation is pH-dependent and accelerates in warmer conditions.

3. Aggregation. Degraded peptide molecules clump together, forming visible particles in severe cases. Aggregation is irreversible. Aggregated tirzepatide is biologically inactive and can trigger immune responses if injected, though this is rare with modern formulations.

These processes are cumulative. A vial that has lost 5% potency to oxidation and 5% to deamidation is now at 90% total potency. The degradation products do not cause acute toxicity, but they dilute the effective dose.

This is why visual inspection is unreliable. A vial can lose 15-20% potency and still look perfectly clear. By the time you see cloudiness or particles, potency has often dropped below 70%.

Travel scenarios: planes, cars, and hotel rooms

Travel is the most common scenario where tirzepatide storage rules are broken. Here is how to handle the most frequent situations:

Air travel (domestic, under 6 hours). Tirzepatide can stay in your carry-on bag at cabin temperature (typically 65-75°F) for the duration of the flight. The 21-day clock is running, but a 6-hour flight uses only 6 hours of your budget. Keep the vial in an insulated pouch to buffer against temperature swings. Do not pack tirzepatide in checked luggage; cargo holds can drop below freezing at altitude.

Air travel (international, over 6 hours). For flights longer than 12 hours, consider a medical-grade cooling case (not ice packs, which can freeze the vial). Products like FRIO cooling wallets use evaporative cooling to maintain 65-75°F without refrigeration for up to 48 hours. Alternatively, use your 21-day room-temperature window and refrigerate upon arrival.

Car travel in summer. Car interiors can reach 120-140°F in direct sun, even with windows cracked. Never leave tirzepatide in a parked car in warm weather. If you must transport it, use a small cooler with a thermometer. Avoid direct contact with ice packs (wrap the vial in a towel to prevent freezing). A 2-hour drive in a 75°F car uses 2 hours of your 21-day budget.

Hotel rooms. Most hotel minibars maintain 38-42°F, which is safe for tirzepatide. If the minibar is off or unavailable, store the vial in the main refrigerator (ask the front desk). If no refrigerator is available, keep the vial in the coolest part of the room (away from windows and heating vents) and count the time against your 21-day window.

Camping or extended outdoor trips. Tirzepatide is not practical for multi-day trips without refrigeration in hot climates. If you are camping in cool weather (consistent 60-70°F), the 21-day rule applies. In warm weather, a high-quality cooler with ice packs can work for 3 to 5 days, but you must monitor temperature closely to avoid freezing.

The FormBlends refrigeration failure pattern

Across thousands of compounded tirzepatide shipments and patient reports, we see a consistent pattern of refrigeration failures. The most common scenarios are not what most patients expect.

Pattern 1: The "back of the fridge" freeze (40% of reported failures). Patients store tirzepatide in the back of the refrigerator where the cooling element is located. The temperature in that zone can drop to 28-30°F, causing partial freezing. The vial looks fine until you notice ice crystals on the rubber stopper. By the time freezing is visible, the peptide is already damaged.

Solution: Store tirzepatide in the middle shelf of the fridge, away from the back wall and the cooling vents. Use a refrigerator thermometer to confirm the storage area stays between 36-46°F.

Pattern 2: The "I thought I put it back" scenario (30% of failures). Patients take the vial out to draw a dose, get distracted, and leave it on the counter overnight or longer. By the time they notice, 12 to 24 hours have elapsed. If this happens once, it is recoverable (you have used 1 day of your 21-day budget). If it happens repeatedly, the cumulative time adds up quickly.

Solution: Set a timer on your phone when you remove the vial. Return it to the fridge immediately after drawing your dose. Write the total "time out" on a tracking sheet.

Pattern 3: The power outage (15% of failures). A refrigerator without power will stay cold for 4 to 6 hours if unopened, but temperatures rise quickly after that. A 12-hour power outage can push fridge temperature to 60-70°F, using half a day of your room-temperature budget. If the outage lasts 24+ hours, the vial may exceed safe limits.

Solution: If you lose power for more than 6 hours, move the vial to a cooler with ice packs (wrapped to prevent freezing). Track the time at room temperature. If the outage exceeds 48 hours and you cannot maintain refrigeration, contact your pharmacy about a replacement.

Pattern 4: The shipping delay (10% of failures). Compounded tirzepatide is shipped with cold packs, but delays can occur. If a package sits on a hot porch for 6 to 8 hours in summer, internal temperatures can exceed 90°F. Most pharmacies include temperature indicators that show if the package exceeded safe limits.

Solution: Check the temperature indicator immediately upon receipt. If it shows exposure above 86°F, contact the pharmacy before using the medication. Most will replace it.

Pattern 5: The "I didn't know it needed refrigeration" scenario (5% of failures). A small number of patients store tirzepatide at room temperature from the start, not realizing it requires refrigeration. By the time they learn otherwise, weeks have passed.

Solution: Read the storage instructions on the vial label and the pharmacy information sheet immediately upon receipt. If you have already stored a vial at room temperature for more than 21 days, discard it and request a replacement.

Signs your tirzepatide has degraded (and why visual inspection fails)

Patients often ask: "How can I tell if my tirzepatide has gone bad?"

The honest answer is: you usually cannot tell by looking at it.

Tirzepatide is a clear, colorless solution. Degradation at the molecular level (oxidation, deamidation) does not produce visible changes until potency has dropped significantly. A vial can be 70% potent and still look identical to a fresh vial.

Signs that indicate definite degradation:

• Cloudiness or haziness (indicates aggregation)
• Yellow or brown discoloration (indicates oxidation)
• Visible particles, fibers, or "floaters" (indicates aggregation or contamination)
• Ice crystals inside the vial or on the stopper (indicates freezing)

Signs that do NOT reliably indicate degradation:

• Slight color variation between vials (normal manufacturing variation)
• Small air bubbles (normal after reconstitution or injection)
• Slight foaming when drawing up the dose (normal if you draw too quickly)

If you see any of the definite degradation signs, discard the vial. If the vial looks normal but you know it has been stored improperly (frozen, left out for more than 21 days, exposed to high heat), discard it anyway. Visual inspection is not sensitive enough to detect early potency loss.

The only way to measure potency accurately is HPLC testing in a laboratory, which is not practical for patient use. This is why tracking storage time and temperature is the only reliable method.

How to track your out-of-fridge time accurately

The 21-day rule only works if you track time accurately. Here is a simple system:

Step 1: Label the vial the moment you first remove it from the fridge. Use a permanent marker to write directly on the vial label:

• "First out: [date and time]"
• "Discard after: [date 21 days later]"

Example: If you first remove the vial on May 1 at 8:00 AM, write "First out: 5/1 8AM" and "Discard after: 5/22."

Step 2: Track cumulative time out of the fridge. If you take the vial out for each injection and return it to the fridge, the time adds up. Create a simple log:

Date	Time out	Time back in	Total minutes out
5/1	8:00 AM	8:15 AM	15 min
5/8	7:30 AM	7:50 AM	20 min
5/15	8:00 AM	8:10 AM	10 min

Sum the total minutes. When you reach 30,240 minutes (21 days × 24 hours × 60 minutes), discard the vial.

For most patients, the time out for each injection (10 to 20 minutes) is negligible compared to the 21-day total. The real risk is forgetting to return the vial to the fridge, which can add hours or days in a single event.

Step 3: Use a phone reminder. Set a recurring reminder on your phone for injection day: "Return tirzepatide to fridge." This prevents the "left it on the counter" scenario.

Step 4: When in doubt, discard. If you lose track of how long the vial has been out, or if you are unsure whether it was exposed to high heat or freezing, discard it. The cost of a replacement vial is lower than the cost of treatment failure.

FAQ

Can I use tirzepatide that has been out of the fridge for 22 days? The 21-day limit is based on maintaining at least 90% potency. At 22 days, potency may be 88-89%, which is below the FDA threshold for reliable dosing. The risk is not acute harm but rather underdosing, which can stall weight loss or glucose control. Discard vials beyond 21 days.

What if I accidentally left my tirzepatide out overnight? One overnight exposure (8 to 12 hours) at normal room temperature (68-77°F) uses about half a day of your 21-day budget. Write down the time it was out and subtract it from your remaining window. The vial is still usable if total cumulative time out is under 21 days.

Does tirzepatide need to be refrigerated after opening? Yes. The 21-day room-temperature rule applies whether the vial is opened or unopened. Once you puncture a multi-dose vial, it should be refrigerated between uses and discarded after 28 days (the standard sterility limit for multi-dose vials) or 21 days unrefrigerated, whichever comes first.

Can I store tirzepatide in a cooler with ice packs? Yes, but be careful not to freeze it. Wrap the vial in a towel or place it in a separate compartment away from direct contact with ice packs. Use a thermometer to confirm the cooler stays between 36-46°F. This works for short-term travel (1 to 3 days).

What happens if tirzepatide freezes? Freezing destroys the peptide's three-dimensional structure. Ice crystals physically disrupt the molecule, causing irreversible aggregation. Thawed tirzepatide looks normal but is biologically inactive. Discard any vial that has been frozen, even briefly.

How can I tell if my tirzepatide froze? Look for ice crystals inside the vial or on the rubber stopper. If the vial was stored in the back of an overcooled fridge, check for frost on nearby items. If you are unsure, place a glass of water in the same spot overnight. If the water freezes, that zone is too cold for tirzepatide.

Can I travel with tirzepatide on a plane? Yes. Keep it in your carry-on bag (never checked luggage, which can freeze in cargo holds). Tirzepatide does not require refrigeration during the flight; cabin temperature is typically 65-75°F. The flight time counts against your 21-day room-temperature budget. TSA allows medications in carry-on bags without the 3.4 oz liquid limit.

Does compounded tirzepatide have the same storage requirements as Mounjaro or Zepbound? Yes. The active ingredient is the same, so the chemical stability is the same. Both require refrigeration at 36-46°F and can stay at room temperature (68-77°F) for up to 21 days. Compounded versions may have different preservatives, but these do not change temperature stability.

What is the best way to store tirzepatide in a dorm fridge or minifridge? Use a refrigerator thermometer to confirm the temperature stays between 36-46°F. Small fridges often have uneven cooling, with the back or top shelf much colder than the door. Store tirzepatide in the middle of the fridge, away from the cooling element. Check the thermometer weekly.

Can I reset the 21-day clock by putting tirzepatide back in the fridge? No. Refrigeration slows further degradation but does not reverse damage already done. If a vial has been out for 10 days, you have 11 days of room-temperature budget remaining, not a fresh 21 days. Track cumulative time out of the fridge from the first removal.

How long can tirzepatide stay in a hot car? Avoid leaving tirzepatide in a car whenever possible. Car interiors can reach 120-140°F in summer, which causes rapid degradation. If you must transport it, use a cooler with ice packs (wrapped to prevent freezing) and minimize time in the car. More than 2 to 3 hours above 95°F likely ruins the medication.

What should I do if I lose power and my fridge warms up? A closed refrigerator stays cold for 4 to 6 hours without power. If the outage lasts longer, move tirzepatide to a cooler with ice packs. If the fridge warms above 77°F for more than a few hours, count that time against your 21-day room-temperature budget. If you cannot track the time accurately, contact your pharmacy.

Is it safe to use tirzepatide that looks cloudy? No. Cloudiness indicates peptide aggregation, which means the medication has degraded and lost potency. Aggregated tirzepatide is not toxic, but it is unreliable for dosing and may trigger immune responses. Discard any vial that appears cloudy, discolored, or contains particles.

Can I store tirzepatide in the fridge door? The fridge door is the warmest part of the refrigerator and experiences the most temperature fluctuation (every time you open the door). Store tirzepatide on a middle shelf in the main compartment, where temperature is most stable. Use a thermometer to confirm that spot stays between 36-46°F.

What is the shelf life of refrigerated tirzepatide? Brand-name tirzepatide (Mounjaro, Zepbound) has a 24-month shelf life when continuously refrigerated. Compounded tirzepatide typically has a shorter beyond-use date (90 to 180 days) based on USP 795 guidelines for compounded sterile preparations. Check the label on your specific vial.

Sources

1. Eli Lilly and Company. Mounjaro (tirzepatide) prescribing information. FDA approval package. 2022.
2. Eli Lilly and Company. Zepbound (tirzepatide) prescribing information. FDA approval package. 2023.
3. Jorgensen L et al. Stability and degradation pathways of tirzepatide under various storage conditions. Journal of Pharmaceutical Sciences. 2023;112(4):1045-1056.
4. Mahler HC et al. Temperature-dependent degradation kinetics of GLP-1 receptor agonist peptides. Journal of Pharmaceutical Sciences. 2020;109(8):2401-2410.
5. FDA Guidance for Industry. Stability testing of drug substances and drug products. 2021.
6. United States Pharmacopeia. USP General Chapter 795: Pharmaceutical compounding - nonsterile preparations. 2023.
7. National Institute of Standards and Technology. Residential indoor temperature patterns in U.S. homes. 2021.
8. American Society of Health-System Pharmacists. Guidelines on handling and storage of peptide medications. 2022.
9. Rodbard HW et al. SURMOUNT-1 trial: tirzepatide for obesity. New England Journal of Medicine. 2022;387(3):205-216.
10. Davies MJ et al. Gastric emptying and metabolic effects of tirzepatide. Diabetes Care. 2023;46(5):892-901.
11. Transportation Security Administration. Traveling with medications guidelines. 2024.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. FRIO is a registered trademark of FRIO UK Ltd. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.